Viewing Study NCT00514293


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-02-23 @ 8:31 PM
Study NCT ID: NCT00514293
Status: UNKNOWN
Last Update Posted: 2014-01-10
First Post: 2007-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: Raghu Nandan, M.D., Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module